SEC Tracker
Get the app

Vaxcyte PCVX

Jim Wassil reports insider trading

Jim Wassil, insider filing for PCVX

Form
4
Filed
Importance
Routine
  1. Oct 5, 2026 - 18,000 shares bought at $5.35
  2. Oct 5, 2026 - 18,000 shares sold at $86.74
  3. Insider is EVP, Chief Scientific Ofc, COO
  4. Trading under Rule 10b5-1 plan

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Vaxcyte files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. PERRIGO PRGO public float $3.7B, Jun 27, 2025
  2. Rhythm Pharmaceuticals RYTM public float $3.8B, Jun 30, 2025
  3. Ultragenyx Pharmaceutical RARE public float $3.4B, Jun 30, 2025
  4. Avidity Biosciences RNAM public float $3.4B, Jun 30, 2025
  5. Soleno Therapeutics SLNO public float $4.1B, Jun 30, 2025